The availability of recombinant human growth hormone (rhGH) has dramatically increased its use in the treatment of short stature, although it is an expensive treatment requiring daily subcutaneous injections. It is also difficult to predict the clinical response to treatment early in the course of treatment.`'-Height velocity changes can, at best, be measured clinically only after four to six months of treatment. Response to treatment in growth hormone deficient children appears to depend partly on the pretreatment variables of age, height, height velocity, skinfold thickness, and growth hormone secretion. 8 In short normal children, greater increases in height velocity were observed in those receiving larger doses of growth hormone. 9 Despite this, precise prediction of growth response to treatment in individual children is difficult; pretreatment and early increases in insulin-like growth factor-l concentrations in response to growth hormone have not been of prognostic value,4 5 though increases in concentration of serum procollagen propeptide after three months of treatment correlate with height velocity changes after one year of treatment (r=0-699, p<0 001). 0 Growth hormone has several metabolic actions, including protein synthesis which is necessary for growth. The early increase in nitrogen balance with rhGH treatment does not predict the subsequent growth response to prolonged treatment. 2 We have previously investigated other measures of the metabolic effect of rhGH and have described a significant increase in fat free mass (FFM) and energy expenditure in a heterogeneous group of patients receiving six weeks of rhGH treatment. In those children the increase in protein synthesis required for the observed increase in FFM to occur was estimated to account for only 7% of the observed increase in resting energy expenditure (REE). " Growth hormone treatment must therefore cause increased energy expenditure in other ways, some of which may be the resultant processes necessary for growth. The existence of such processes might explain the poor predictive value of nitrogen retention in determining the growth response to rhGH.
We hypothesised therefore that early changes in REE and total free living energy expenditure (TEE) in response to rhGH treatment (that may be only partially indicative of the anabolic effect of rhGH) may nevertheless predict the long term effects of rhGH on growth. We therefore carried out studies to investigate the changes in body composition and energy expenditure during one year of rhGH treatment. We also assessed the value of the observed early changes in these variables in predicting the long term growth response to continuous rhGH treatment. We report the findings here.
Subjects and methods Ethical approval for the study was obtained from the committee on medical ethics of Tayside Health Board. Fifteen patients were recruited from the children's endocrine clinic as previously reported." This paper reports the long term results from 14 of these patients (eight boys and six girls, mean (range) age 9-9 (74-13-7) years, pretreatment height SD score -2-2 (-4-6 to +11) and height velocity 4 9 (3-1-8-3) cm/year) as one patient with normal variant short stature dropped out of the study after six weeks. Change in fat mass (kg) Figure 3 Relationship between changes infat mass (six weeks) and height velocity (six months).
initial change in fat mass would be -011 to 7- The finding that, six week increases in FFM do not correlate with six month increases in height velocity in the study group as a whole, is in keeping with previous studies reporting the lack of correlation between early estimates of nitrogen retention and longer term growth. 2 7 Though increments in FFM might be expected to be a measure of the anabolic effect of rhGH, the calorigenic effect of rhGH treatment is greater than that produced by the presumed increase in protein synthesis." We hypothesise that other unknown effects of rhGH, for example, factors affecting sodium pump activity and cardiovascular energy expenditure may be related to growth response.
In conclusion, we have demonstrated that the effects of rhGH treatment on REE per kg FFM and on the extent of changes in body composition decreased after six weeks of treatment. Nevertheless, six week changes in fat mass, REE, and TEE are significantly correlated with six month increases in height velocity. In clinical practice, the 95% prediction intervals of the equation (fig 3) are wide and limit the precision of the predicted increase in height velocity for individual patients. The data suggest that further, larger studies are indicated to assess the value of measurements of the early changes in body composition in the prediction of the long term growth response to rhGH treatment. 
